116 related articles for article (PubMed ID: 32985057)
1. Pediatric diabetes and skin disease (PeDiSkin): A cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes.
Burgmann J; Biester T; Grothaus J; Kordonouri O; Ott H
Pediatr Diabetes; 2020 Dec; 21(8):1556-1565. PubMed ID: 32985057
[TBL] [Abstract][Full Text] [Related]
2. High frequencies of dermatological complications in children using insulin pumps or sensors.
Berg AK; Olsen BS; Thyssen JP; Zachariae C; Simonsen AB; Pilgaard K; Svensson J
Pediatr Diabetes; 2018 Jun; 19(4):733-740. PubMed ID: 29484783
[TBL] [Abstract][Full Text] [Related]
3. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
[TBL] [Abstract][Full Text] [Related]
4. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
5. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
[TBL] [Abstract][Full Text] [Related]
6. Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type.
Franceschi R; Pertile R; Marigliano M; Mozzillo E; Maffeis C; Morotti E; Di Candia F; Fedi L; Iafusco D; Zanfardino A; Cauvin V; Maltoni G; Zucchini S; Cherubini V; Tiberi V; Minuto N; Bassi M; Rabbone I; Savastio S; Tinti D; Tornese G; Schiaffini R; Passanisi S; Lombardo F; Bonfanti R; Scaramuzza A; Troncone A
Diabet Med; 2024 Jun; 41(6):e15307. PubMed ID: 38383984
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.
Diedisheim M; Pecquet C; Julla JB; Carlier A; Potier L; Hartemann A; Jacqueminet S; Vidal-Trecan T; Gautier JF; Dubois Laforgue D; Fagherazzi G; Roussel R; Larger E; Sola-Gazagnes A; Riveline JP
Diabetes Technol Ther; 2023 Apr; 25(4):279-286. PubMed ID: 36763338
[No Abstract] [Full Text] [Related]
9. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
[TBL] [Abstract][Full Text] [Related]
10. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
11. Technology use and clinical outcomes in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes.
Baboun D; Solano N; Del Toro V; Alvarez-Salvat R; Granados A; Carrillo-Iregui A
J Pediatr Endocrinol Metab; 2023 Dec; 36(12):1128-1132. PubMed ID: 37852007
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
[TBL] [Abstract][Full Text] [Related]
13. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
[TBL] [Abstract][Full Text] [Related]
14. Preserving Skin Integrity with Chronic Device Use in Diabetes.
Messer LH; Berget C; Beatson C; Polsky S; Forlenza GP
Diabetes Technol Ther; 2018 Jun; 20(S2):S254-S264. PubMed ID: 29916740
[TBL] [Abstract][Full Text] [Related]
15. Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue.
Lombardo F; Salzano G; Crisafulli G; Panasiti I; Alibrandi A; Messina MF; Pajno GB; Caminiti L; Passanisi S
Diabetes Res Clin Pract; 2020 Apr; 162():108089. PubMed ID: 32087268
[TBL] [Abstract][Full Text] [Related]
16. POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY.
Peters A; Van Name MA; Thorsted BL; Piltoft JS; Tamborlane WV
Endocr Pract; 2017 Oct; 23(10):1201-1209. PubMed ID: 28704103
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
19. Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.
Christensen MO; Berg AK; Rytter K; Hommel E; Thyssen JP; Svensson J; Nørgaard K
Diabetes Technol Ther; 2019 Apr; 21(4):215-221. PubMed ID: 30943072
[TBL] [Abstract][Full Text] [Related]
20. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
Dicembrini I; Mannucci E; Monami M; Pala L
Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]